Details for: CL1001474

Cell ID: CL1001474

Cell Name: medium spiny neuron

Description: An inhibitory, GABAergic projection neuron in the striatum that integrates glutamatergic signals arising from the cerebral cortex and thalamus.

Synonyms: gamma-aminobutyric acid (GABA)ergic spiny projection neuron, gamma-aminobutyric acid ergic spiny projection neuron, medium-sized densely spiny neuron, striatal medium spiny neuron

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for medium spiny neuron within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for medium spiny neuron. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for medium spiny neuron. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for medium spiny neuron. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  medium spiny neuron (CL1001474)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [medium spiny neuron](/details-cell/CL1001474) is a GABAergic inhibitory projection neuron integral to the function of the striatum. Based on its gene significance profile, this cell's identity is strongly defined by a unique combination of transcriptional regulators and chromatin modifiers, such as [CAMTA1](/details-gene/23261) and [ARID1B](/details-gene/57492). This suggests that a highly specific epigenetic and transcriptional landscape is crucial for establishing and maintaining its specialized role in integrating cortical and thalamic inputs. Concurrently, the high specificity of genes involved in synaptic signaling ([GRM5](/details-gene/2915)), ion transport ([KCNIP4](/details-gene/80333)), and post-transcriptional regulation ([TNRC6B](/details-gene/23112)) underscores its complex functional capacity for signal processing and plasticity within the basal ganglia circuitry. ## Key Characteristics and Function **Overall**, the gene expression profile of the [medium spiny neuron](/details-cell/CL1001474) highlights its specialization in neuronal signaling, development, and the precise regulation of its own genetic programming. The top markers, identified by high `csi_z` scores, can be grouped into several key functional clusters. * **Transcriptional and Chromatin Regulation:** A prominent feature of this neuron is the high specificity of genes involved in controlling gene expression. Top markers include [CAMTA1](/details-gene/23261) (a transcription coregulator), [ARID1B](/details-gene/57492) (a component of the SWI/SNF chromatin remodeling complex), [KMT2C](/details-gene/58508) (a histone methyltransferase), and [KANSL1](/details-gene/284058) (part of a histone acetyltransferase complex). This indicates that the unique identity and function of [medium spiny neurons](/details-cell/CL1001474) are maintained by a distinct and stable epigenetic state. * **Synaptic Signaling and Structure:** As expected for a neuron, genes critical for synaptic function are highly specific. This includes [GRM5](/details-gene/2915), a metabotropic glutamate receptor vital for processing excitatory inputs, and [GABRB1](/details-gene/2560), a subunit of the GABA-A receptor that mediates its inhibitory output. Furthermore, genes like [LRRTM3](/details-gene/347731), which is involved in synapse assembly, and [CSMD3](/details-gene/114788), implicated in dendrite development, point to the active maintenance of synaptic architecture. The high significance of [APP](/details-gene/351), the amyloid precursor protein, is also notable in this context. * **Ion Channel Activity:** Neuronal excitability is underscored by the specificity of ion channel components. Key markers include [KCNIP4](/details-gene/80333), which modulates potassium channel activity, and [CACNG3](/details-gene/10368), an auxiliary subunit of voltage-gated calcium channels. These proteins are essential for shaping the action potential and regulating neurotransmitter release. * **RNA and Protein Homeostasis:** The cell appears to rely on specialized post-transcriptional and post-translational control mechanisms. The high specificity of [TNRC6B](/details-gene/23112), a key component of P-bodies involved in RNA silencing, and [TTC3](/details-gene/7267), a ubiquitin-protein ligase, suggests that the regulation of mRNA turnover and protein degradation are not merely housekeeping functions but are tailored to the specific needs of this neuron. The anti-markers further refine the cell's profile. The low significance of genes involved in general cellular processes like mRNA splicing ([HNRNPR](/details-gene/10236), [HNRNPA2B1](/details-cell/CL0000811)) and cell cycle progression ([USP22](/details-gene/23326), [ANAPC16](/details-gene/119504)) is consistent with a terminally differentiated, post-mitotic cell whose specialization lies beyond these ubiquitous functions. ## Clinical Significance and Contextual Roles The gene significance profile of the [medium spiny neuron](/details-cell/CL1001474) reveals strong connections to several neurodevelopmental and neurodegenerative disorders. The high specificity of [APP](/details-gene/351) (CSI: 10.29) directly implicates this cell type in the pathophysiology of Alzheimer's disease, where the processing of APP is a central event ([Link](https://pubmed.ncbi.nlm.nih.gov/2881207/)). This suggests that [medium spiny neurons](/details-cell/CL1001474) may be particularly involved in, or vulnerable to, amyloid-beta pathology. Furthermore, several top markers are linked to neurodevelopmental conditions. Mutations in [ARID1B](/details-gene/57492) are a leading cause of intellectual disability and Coffin-Siris syndrome. The high specificity of [TTC3](/details-gene/7267), located in the Down syndrome critical region on chromosome 21, suggests its potential involvement in the neurological phenotypes associated with this condition ([Link](https://pubmed.ncbi.nlm.nih.gov/8724848/)). The presence of genes like [NTRK3](/details-gene/4916) and [NRG3](/details-gene/10718), both involved in neurotrophic signaling pathways, as significant markers suggests that the survival and maintenance of these neurons are dependent on specific growth factor signaling, the disruption of which could contribute to their degeneration in diseases like Huntington's disease, where [medium spiny neurons](/details-cell/CL1001474) are preferentially lost. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The unique identity and selective vulnerability of [medium spiny neurons](/details-cell/CL1001474) are dictated by a specific "epigenetic code" maintained by a combination of chromatin-modifying enzymes and transcription factors, including [ARID1B](/details-gene/57492), [KMT2C](/details-gene/58508), and [CAMTA1](/details-gene/23261). Dysregulation of this regulatory network may be an early event in neurodegenerative diseases that affect the striatum. * **Surprising Findings:** The observation that chromatin regulators ([ARID1B](/details-gene/57492), [KMT2C](/details-gene/58508)) rank as more specific markers than many canonical synaptic proteins suggests that the fundamental identity of this neuron is rooted more deeply in its transcriptional control architecture than in its expressed functional machinery alone. * **Testable Questions:** Does conditional knockout of [ARID1B](/details-gene/57492) specifically in striatal [medium spiny neurons](/details-cell/CL1001474) in a mouse model lead to a progressive loss of cell-specific gene expression and subsequent neurodegeneration, mimicking aspects of striatal pathology? 2. **Hypothesis:** Specialized post-transcriptional and protein degradation pathways, governed by highly specific factors like [TNRC6B](/details-gene/23112) and [TTC3](/details-gene/7267), are essential for managing local protein synthesis and turnover at the synapse, thereby controlling synaptic plasticity. Failure of these quality control systems could lead to the accumulation of misfolded or aggregated proteins, a hallmark of neurodegeneration. * **Surprising Findings:** The high `csi_z` score for [TNRC6B](/details-gene/23112), a core component of P-bodies, implies that mRNA sequestration and decay are not generic housekeeping processes in these neurons but are highly specialized functions, perhaps tailored to regulate specific synaptic transcripts in an activity-dependent manner. * **Testable Questions:** Using proximity-labeling mass spectrometry, what is the specific repertoire of mRNAs and proteins that interact with [TNRC6B](/details-gene/23112) in [medium spiny neurons](/details-cell/CL1001474) at baseline versus after pharmacologically induced long-term depression, and do these targets include proteins implicated in neurodegenerative diseases?